Loading...

News

News

Post Types

Arkstone Now Factors Pregnancy for the OneChoice Report and MedsMatrix

BOCA RATON, Fla., July 25, 2022 - Arkstone Medical Solutions, the leading provider of molecular laboratory infectious disease reporting and proactive antimicrobial stewardship, has once again raised the bar in infectious disease analysis for molecular laboratory results, adding pregnancy as a factor considered by the OneChoice Report and MedsMatrix.  Thousands of healthcare providers already rely … Arkstone Now Factors Pregnancy for the OneChoice Report and MedsMatrix">Continue reading Arkstone Now Factors Pregnancy for the OneChoice Report and MedsMatrix

Ovation Announces Partnership with Arkstone to Provide Actionable Antibiotic Treatment Recommendations

Ovation, the premier LIMS/LIS software provider for molecular diagnostic laboratories, is proud to announce a new partnership and integration with Arkstone Medical Solutions, the leading provider of molecular laboratory infectious disease reporting and proactive antimicrobial stewardship.  Ovation LIMS/LIS enables prominent molecular diagnostic laboratories to provide comprehensive test results to thousands of clinicians nationwide. Now, these … Ovation Announces Partnership with Arkstone to Provide Actionable Antibiotic Treatment Recommendations">Continue reading Ovation Announces Partnership with Arkstone to Provide Actionable Antibiotic Treatment Recommendations

Arkstone’s Launches Revolutionary MedsMatrix

Arkstone Medical Solutions, the leading provider of molecular laboratory infectious disease reporting and proactive antimicrobial stewardship, once again has raised the bar of infectious disease analysis of molecular laboratory results, with the launch of its newest feature- MedsMatrix™. Thousands of healthcare providers already rely on Arsktone’s OneChoice report, and it's innovative and informative overreads of … Arkstone’s Launches Revolutionary MedsMatrix">Continue reading Arkstone’s Launches Revolutionary MedsMatrix

Juan Carlos Gómez de la Torre becomes Arkstone’s Director of Molecular Informatics

Arkstone Medical Solutions, the leading provider of infectious disease laboratory result interpretations and proactive antimicrobial stewardship, is pleased to announce the appointment of Dr. Juan Carlos Gómez de la Torre Pretell, founder of the Peruvian Institute of Molecular Biology, as Arktone’s new Director of Molecular Informatics.  Dr. Gómez de la Torre Pretell will be an … Juan Carlos Gómez de la Torre becomes Arkstone’s Director of Molecular Informatics">Continue reading Juan Carlos Gómez de la Torre becomes Arkstone’s Director of Molecular Informatics
Arkstone’s Antimicrobial Stewardship Program (ASP) Provides Skilled Nursing Facilities with Advanced Cost Effective Program

Arkstone’s Antimicrobial Stewardship Program (ASP) Provides Skilled Nursing Facilities with Advanced Cost Effective Program

The Antimicrobial Stewardship Monthly Report includes month-to-month tracking of infections from many different sources, including respiratory, wound, urine, and GI. The report breaks down the most common types of infections and resistance genes and analyzes this data so that trends are easily visible, allowing for the implementation of proactive surveillance and infection control policies.
Arkstone Updates ArkScore System to Provide Unmatched Physician Experience

Arkstone Updates ArkScore System to Provide Unmatched Physician Experience

The improved ArkScore interprets the complex results of a molecular diagnostic test and presents an optimal course of treatment. This simplification allows each physician to quickly understand how treatment options are affected by the patient’s profile, presence of specific organisms, and resistance genes.
Arkstone Files Patents Focused on Helping Physicians Prescribe Responsibly

Arkstone Files Patents Focused on Helping Physicians Prescribe Responsibly

Arkstone Medical Solutions has filed Provisional U.S. Patent Applications covering technologies that aid physicians in making educated and informed decisions for patient care. These systems are already in use on the renowned Arkstone Report, which analyzes molecular diagnostic lab results and guides physicians with pinpoint interpretations and recommendations.
Arkstone Incorporates Patient Allergies Into Its Already Powerful Analysis Toolkit

Arkstone Incorporates Patient Allergies Into Its Already Powerful Analysis Toolkit

Arkstone's OneChoice technology automatically analyzes many factors like specimen source, organisms and genes detected, patient age and gender, and diagnosis, to arrive at a targeted precision-guided treatment recommendation. By incorporating which antibiotics the patient may be allergic to, the recommendations are now even more tailored to the specific patient's needs.
Next